Implications of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis

Advances in Experimental Medicine and Biology

Volumn 649, Issue , 2009, Pages 177-194

  Ziegler, Andreas ^a   Loll, Bernhard ^a   Misselwitz, Rolf ^a   Uchanska Ziegler, Barbara ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; LATENT MEMBRANE PROTEIN 2; M9 PEPTIDE; PEPTIDE DERIVATIVE; PROTEIN ARST1; REGULATOR PROTEIN; TIS PEPTIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; ISOPROTEIN; PEPTIDE; VIRUS PROTEIN;

ANKYLOSING SPONDYLITIS; ARST1 GENE; ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CROSS REACTION; DISEASE ASSOCIATION; GENETIC ASSOCIATION; HISTOCOMPATIBILITY GENE; HLA B27 GENE; HUMAN; MARKER GENE; MOLECULAR MIMICRY; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STABILITY; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION; THERMAL ANALYSIS; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY; ALLELE; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM; REVIEW;

ALLELES; CRYSTALLOGRAPHY, X-RAY; HLA-B27 ANTIGEN; HUMANS; MODELS, MOLECULAR; MOLECULAR MIMICRY; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION; PROTEIN ISOFORMS; SPONDYLITIS, ANKYLOSING; THERMODYNAMICS; VIRAL PROTEINS;

EID: 70349567381     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0298-6_13     Document Type: Article

References (66)

1. WTCCC TASC. A genome-wide scan of 14, 000 nonsynonymous coding SNPs in 5.500 individuals: The wellcome trust case control consortium. Nat Genet 2007; 39:1329-1337.
2. Khan MA, Mathieu A, Sorrentino R et al. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev 2007; 6:183-189 . (Pubitemid 46187337)
3. López de Castro JA. HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 2007; 108:27-33.
4. Taurog JD. The mystery of HLA-B27: If it isn't one thing, it's another. Arthritis Rheum 2007; 56:2478-2481. (Pubitemid 47237266)
5. Brown MA. Breakthroughs in genet ic studies of ankylosing spondylitis. Rheumatol 2008; 47:132-37. (Pubitemid 351168219)
6. Fiorillo MT. Cauli A, Carcassi C et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: Implications for disease pathogenesis. Arthritis Rheum 2003; 48:1385-1389. (Pubitemid 36554537)
7. Cascino I. Paladini F. Belfiore F et al. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in sardinia. Arthritis Rheum 2007; 56:2640-2651. (Pubitemid 47237282)
8. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11:137-142 .
9. Allen RL, O'Callaghan CA , McMichael AJ et al. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999; 162:5045-5048. (Pubitemid 29307101)
10. Colbert RA. HLA-B27 misfolding: A solution to the spondyloarrhropathy conundrum? Mol Med Today 2000; 6:224-230. (Pubitemid 30394908)
11. Uchanska-Ziegler B. Ziegler A. Ankylosing spondylitis: A β2m-deposition disease? Trends Immunol 2003; 24:73-76.
12. 2-microglobulin rearranges to auto-display or cross-display residues 169-181: A novel molecular mechanism for spondyloarthropachies. FEBS Lett 2004; 24:1-8. (Pubitemid 39237672)
13. Penttinen MA, Heiskanen KM, Mohaparra R et al. Enhanced intracellular replication of Salmonella enteridis in HLA-B27-expressing human monocytic cells: Dependency on glutamic acid at position 45 in the B pocket of HLA-B27. Arthritis Rheum 2004; 50:2255-2263. (Pubitemid 38924404)
14. Hammer RE, Maika SD, Ricjardson JA et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders . Cell 1990; 63:1099-1112. (Pubitemid 120034950)
15. Lang HL, Jacobsen H, Ikemizu S et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002; 3:940-943. (Pubitemid 35154007)
16. Bjorkman PJ, Saper MA, Samraoui B et al. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329:506-512. (Pubitemid 17131093)
17. Madden DR, Gorga JC , Strominger JL et al. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991; 353:321-325. (Pubitemid 21912496)
18. Madden DR, Gorga JC, Strominger JL et al. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992; 70:1035-1048.
19. Brewerton DA, Hart FD, Nicholls A et al. Ankylosing spondylitis and HLA-B27. Lancet 1973; 1:904-907.
20. Schlosstein L, Terasaki PI, Bluestone R et al. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288:704-706.
21. Gaston H. Mechanisms of disease: The immunopathogenesis of spondyloarthropathies. Nat Clin Pract Rheumatol 2006; 2:383-392.
22. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007; 369:1379-1390. (Pubitemid 46590387)
23. Natarajan K, Li H, Mariuzza RA et al. MHC class I molecules, structure and function. Rev Immunogenet 1999; 1:32-46.
24. Borrego F. Kabat J. Kim DK et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressedon human natural killer (NK) cells. Mol Immunol 2002; 38:637-660. (Pubitemid 34168194)
25. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immuno1 1995; 13:587-622.
26. Dangoria NS. DeLay M, Kingsbury DJ et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002; 277:23459-23468. (Pubitemid 34952180)
27. López-Larrea C. Sujirachato K, Mehra NK et al. HLA-B27 subtypes in asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995; 45:169-176.
28. Gonzalez-Roces S, Alvarez MV, Gonzalez S et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997; 49:116-123. (Pubitemid 27084693)
29. D'Amaro M. Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995; 25:3199-3201.
30. Nasution AR, Mardjuati A, Kunmartini S et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy, J Rheumatol 1997; 24:1111-1114. (Pubitemid 27250118)
31. *2709 to ankylosing pondylitis correlates with limited peptide subsets but not with altered cell surface stability. J Biol Chem 2002; 277:28749-28756.
32. *2706) differ by specific changes at three anchor positions. J Biol Chem 2002; 277:16744-16749. (Pubitemid 34967695)
33. *1403. Arthritis Rheum 2007; 56:2807-2809. (Pubitemid 47237304)
34. Fiorillo MT, Maragno M. Butler R et al. CD8+ T-cell autoreactiviry to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J Clin Invest 2000; 106:47-53. (Pubitemid 30437239)
35. Garboczi DN, Hung DT. Wiley DC. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single peptides. Proc Natl Acad Sci USA 1992; 89:3429-3433.
36. Hülsmeyer M, Hillig RC, Volz A et al. HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem 2002; 277:47844-47853. (Pubitemid 36159311)
37. Hülsmeyer M, Welfle K, Pöhlmann T et al. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J Mol Biol 2005; 346:1367-1379. (Pubitemid 40248835)
38. Fiorillo MT, Rückert C. Hülsmeyer M et al. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem 2005; 280:2962-2971. (Pubitemid 40189406)
39. Hülsmeyer M, Fiorillo MT, Bettosini F et al. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med 2004; 199:271-281. (Pubitemid 38139247)
40. Rückert C, Fiorillo MT, Loll B et al. Conformational dimorphism of self-pepcides and molecular mimicry in a disease-associated HLA-B27 subtype. J Biol Chem 2006; 281:2306-2316. (Pubitemid 43845822)
41. *2703 complexed with a viral peptide and with a self-peptide. Acta Cryst F 2005; 61:372-374. (Pubitemid 44210893)
42. *2704 in complex with a viral peptide and with a self-peptide. Acta Cryst F 2005; 61:939-941. (Pubitemid 44210765)
43. *2706 in complex with a viral peptide and with a self-peptide. Acta Cryst F 2005: 61:1097-1099. (Pubitemid 44210725)
44. Hillikg RC, Hülsmeyer M, Saenger W et al. Thermodynamic and structural analysis of peptide-and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J Biol Chem 2004: 279:652-663. (Pubitemid 38044870)
45. Pöhlmann T, Böckmann RA, Grubmüller H et al. Differential peptide dynamics is linked to MHC polymorphism. J Biol Chem 2004: 279:28197-28201. (Pubitemid 38900095)
46. Winkler K, Winter A, Rückert C et al. Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes. Biophys J 2007; 93:2743-2755. (Pubitemid 47607811)
47. Fabian H, Huser H, Narzi D et al. HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution. J Mol Biol 2008; 376:798-810.
48. López de Castro JA, Alvarez I, Marcilla M et al. HLA-B27: A registry of constitutive peptide ligands. Tissue Antigens 2004; 63:424-445. (Pubitemid 38648208)
49. *2709 molecules complexed with the same peptide. In: Hansen JA. ed. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Congress. Vol. I. Seattle: IHWG Press. 2006:138-147.
50. Herberts CA, Neijssen JJ, de Haan J et al. Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation. J Immunol 2006; 176:2697-2701.
51. Ziegler A, Loll B, Kellermann T et al. A cartilage-derived self peptide presented by HLA-B27 molecules? Comment on the article by Atagunduz and colleagues. Arthritis Rheum 2005: 52:2581-2582.
52. Atagunduz P, Appel H, Kuon W et al. HLA-B27-restricted CD8+ T-cell response to cartilage-derived self peptide s in ankylosing spondylitis. Arthritis Rheum 2005: 52:892-901. (Pubitemid 40365113)
53. *2709) differentially associated to ankylosing spondylitis. J Immunol 1999: 163:2299-2305.
54. Brooks JM, Murray RJ. Thomas WA et al. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med 1993: 178:879-887. (Pubitemid 23260425)
55. Earnest T, Fauman E, Craik CS et al. 1.59 Å structure of trypsin at 120 K: Comparison of low temperature and room temperature structures. Proteins 1991: 10:171-187.
56. Tilton RF, Dewan JC, Petsko GA. Effects of temperature on protein structure and dynamics: X-ray crystallographic studies of the protein ribonuclease-A at nine different temperatures from 98 to 320 K. Biochem istry 1992: 31:2469-2481.
57. Pace CN, Scholtz JM. Measuring the conformational stability of a protein. In: Creighton TE. ed. Protein Structure. A Practical Approach. 2nd ed. Oxford: Oxford lRL Press, 1997:299-321.
58. *2705 peptide complexes. Effect of peptide and major histocompatibility complex protein mutations. J Biol Chem 2000: 275:27055-27061.
59. Alexiev U, Rimke I, Pöhlmann T. Elucidation of the nature of the conformational changes of the EF-interhelical loop in bacteriorhodopsin and of the helix VIII on the cytoplasmic surface of bovine rhodopsin: A time-resolved fluorescence depolarization study. J Mol Biol 2003: 328:705-719. (Pubitemid 36438583)
60. Fabian H, Mäntele W. Infrared spectroscopy of proteins. In: Chalmers JM, Griffiths PR, eds. Handbook of Vibrational Spectroscopy. Chichester: Wiley. 2002:3399-3425.
61. Barth A, Zscherp C. What vibrations tell us about proteins. Q Rev Biophys 2002: 35:369-430. (Pubitemid 36207229)
62. Privalov PL, Potekhin SA. Scanning microcalorimetry in studying temperature-induced changes in proteins. Methods Enzymol 1986; 131:4-51. (Pubitemid 16002194)
63. Rudolph MG, Luz JG, Wilson IA. Structural and thermodynamic correlates of T-cell signaling. Annu Rev Biophys Biomol Strucr 2002: 31:121-149. (Pubitemid 34666828)
64. Tran TM, Dorris ML. Sarumtira N et al. Additional human beta2m curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27 transgenic rats. Arthritis Rheum 2006: 54:1317-1327. (Pubitemid 43672945)
65. Fukunishi S, Yoh K, Kamae S et al. Beta 2-microglobulin amyloid deposit in HLA-B27 transgenic rats. Mod Rheumatol 2007; 17:380-384. (Pubitemid 47593485)
66. Uchanska-Ziegler B. Ziegler A. HLA-B27-transgenic rats, amyloid deposits, and spondyloarthroparhies. Mod Rheumatol 2008: doi: 1O.1007/s10165-008-0066-8.